Skip to main content
Clinical Trials/NCT07313397
NCT07313397
Not yet recruiting
Not Applicable

Nurse-led and GP-supported Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer Survivors With Cardiovascular Diseases

University of Southern Queensland3 sites in 1 country15 target enrollmentStarted: March 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
15
Locations
3
Primary Endpoint
Baseline Information

Overview

Brief Summary

The goal of this proposed single-group pre-post pilot study is to assess the feasibility and acceptability of the codesigned Nurse-led and GP-supported self-management interventions (NGPS) to reduce cardiovascular risks in breast cancer survivors with cardiovascular diseases. The study will also assess the preliminary effects of the NGPS intervention on various outcomes, such as behavioural, physiological, psychological, and healthcare usage. These outcomes will be measured at three time points, which include the baseline measurement at recruitment (T1-week 1), right after the four weeks' intervention (T2-week 4), and eight weeks after completing the intervention (T3-week 12). The study will be conducted in the primary care centres, and the self-management interventions are behavioural change interventions such as physical activity, diet modifications, tobacco cessation, weight management, eliminating or reducing alcohol consumption, and mind-body exercises such as yoga. The main questions it aims to answer are:

  1. What are the recruitment, retention, attrition, and completion rates of participants and potential adverse effects related to the NGPS interventions for the participants throughout the pilot study?
  2. What are the adherence rates of the NGPS protocol, participants' response and completion rates of the study instruments during the data collection period of the pilot study?
  3. Do this pilot study results indicate any significant differences in cardiovascular health outcomes (e.g., BMI and blood pressure), physical activity, dietary intake, QoL, self-efficacy, anxiety and depression between and across different time points (Baseline (T1), post-intervention (T2), follow-up (T3))?

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • aged 18 years or older
  • confirmed diagnosis of breast cancer at stage I, II, or IIIa
  • confirmed diagnosis of CVDs, including heart failure, coronary artery disease, stroke, or transient ischemic attack
  • able to read, write, and communicate in English
  • have completed active anticancer treatment including chemotherapy and radiotherapy, and are receiving regular healthcare in a primary care centre from GP/practice nurses and are willing to participate in the research study and provide informed consent.

Exclusion Criteria

  • patients with unstable health conditions with mental health issues or critically ill patients unable to participate in physical activities (e.g., suffering from life-threatening diseases, extremely weak), cognitive impairment, currently involved in another research study, or scheduled anticancer treatment during the study period.

Outcomes

Primary Outcomes

Baseline Information

Time Frame: Once at baseline

Collect socio-demographic characteristics of the breast cancer survivors such as age, height, race/ethinicity, religion, education level, marital status, employment status and annual household income as well as medical history

Feasibility of recruitment

Time Frame: From recruitment start (Day 1 of the recruitment) to recruitment close (the day that the target sample reached), up to 12 months

Number of weeks/months needed to reach target sample size

Recruitment rate

Time Frame: Recruitment rate will be assessed monthly over the recruitment period (up to 12 months).

The percentage of eligible (or approached) participants who actually agree to take part in the study.

Retention rate

Time Frame: Across the entire trial period, from enrolment to eight weeks post study follow-up

The percentage of participants who remain in the study

Dropout rate

Time Frame: Across the entire trial period, from enrolment to eight weeks post study follow-up

The percentage of participants dropped out after the study enrolment

Feasibility of the questionnaires

Time Frame: Across the entire trial period, from enrolment to eight weeks post study follow-up

The percentage of missing responses for each item and the entire scale in each questionnaires

Feasibility and acceptability of the study intervention- Adherence rate

Time Frame: From week one to week four, during the intervention period

The percentage of participants who followed the prescribed interventions as intended

Safety of the intervention- Adverse Events related to the Nurse-led and GP-supported self-management (NGPS) intervention

Time Frame: From week one to week four, during the intervention period

Asking the participants to record any discomfort feelings or adverse events related to the NGPS intervention, keeping daily logbook and report via telephone or face-to-face

Acceptability of the intervention

Time Frame: At eight-week follow up

Feedback on the NGPS program will be gained by using an investigator-created questionnaire. Participants are asked to specify the extent to which they agree with each statement about the intervention by selecting one response option that best indicates their views. The numeric value will range from 1 to 5, where 1 indicates strongly disagree, 2 indicates disagree, 3 indicates neither agree nor disagree, 4 indicates agree, and 5 indicates strongly agree. The minimum value is 1, and the maximum score is 5. Higher scores indicate greater acceptability of the intervention and a better outcome.

Secondary Outcomes

  • Physiological outcomes- BMI(At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3))
  • Physiological outcomes-blood pressure(At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3))
  • Physiological outcomes-heart rate(At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3))
  • Behavioural outcomes using 15-item food frequency questionnaire(At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3))
  • Behavioural outcomes- Self-reported smoking status(At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3))
  • Behavioural outcomes-Physical activity assessment using the International Physical Activity Questionnaire(At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3))
  • Psychological outcome-Self efficacy(At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3))
  • Psychological outcomes-Quality of Life(At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3))
  • Psychological outcome-Anxiety and Depression(At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3))
  • Healthcare usage(From week one to week four, during the intervention period and at eight week follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Anu Correya

Principal Investigator

University of Southern Queensland

Study Sites (3)

Loading locations...

Similar Trials